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v 202 ± 35, p = 0.04) and FRP (PCL 400, 296 ± 44 v 262 ± 27, p = 0.02)
measurements than pts who did not develop AI' Immediately after CPB con-
duction velocity shortened but no overall change in wavelength indices (WL
~ CV x ERPI was noted. By postoperative day 1 (POD 1) conduction ve-
locity returned to baseline values and no consistent differences in ERP or
FRP dispersion or wavelength indices were subsequently detected. How-
ever, refractory periods became shorter than preCPB values by POD 1 with
unchanged or shortening of refractory periods noted on subsequent POD
2-4.
to sinus rhythm during PROC. Left atrial appendage emptying velocities
(LA-EV) and filling velocities (LA-FV) were measured (m/sec) with pulsed
wave Doppler pre- and post-cardioversion. SC in the left atrium was visually
graded.
PROC ECV
LA-EV LA-FV LA-EV LA-FV
pre 0.68 ± 0.2 0.64 ± 0.2 0.42 ± 0.09# 0.44±014
post 0.34 ± 0.06' 0.44 ± 0.22' 0.16 ± 0.06'# 0.23±014'
*p < 0,05 paired t-test comparisons to PreCPB values
Comparison of Pulmonary Artery vs. Coronary
Sinus Lead Position for Low Energy Conversion
of Atrial Fibrillation
Reduction in Ventricular Response During Atrial
Fibrillation After Ablation of the Slow Pathway:
Acute Results and Follow-up
Background: Animal studies show that low energy inlracardiac conversion
(IC) of atrial fibrillation (AF) is feasible. A lead position in the distal coronary
sinus (CS) vs. right atrium (RA) showed lower energy levels for conversion
than left pulmonary artery (PA) vs. RA.
Methods: Cardioversion was attempted in 25 patients (pts). 15 randomized
to the CS/RA lead position and 10 to PNRA. The CS group consisted of 4
females, mean age at 60.2 ± 8.2 years, left atrial diameters ranged from 54
to 71 mm with a mean of 59.2 ± 4.9 mm, AF duration was 9.5 ± 9.0 months
(range 1-36 months). The PA group consisted of 3 females, mean age 60.5 ±
10.5 years, left atrial diameters ranged from 54 to 76 mm with a mean of 64,5
± 6.6 mm, AF duration was 13.7 ± 22 months (0.5-79 months). There were
no significant differences between the two groups. Biphasic shocks (3 ms
+ 2 ms) were R-wave triggered and delivered in increments of 40 V from an
external defibrillator (Ventritex HVS 02, Sunnyvale, CAl via two custom made
catheters (6 F, Elecath Inc., Rahway, NJ) to a maximum energy of 11.1 J or
successful conversion to sinus rhythm. Pts were sedated with midazolam.
Results: In the CS group conversion in 13/15 pts was achieved at a mean
energy level of 3.7 ± 1.6 J, range 1.0-6.6 J. Mean lead impedance was 58.8 ±
7.5 Q. In the PA group, IC was successful in 9/10 pts, the mean energy level
was 4.4 ± 2.' J, range 2.5--11.1 J. Mean lead impedance was 59.1 ± 10.0 Q.
No severe complications were observed in either lead position group. There
was no significant difference between CS and PA.
Conclusions: Low energy biphasic shocks delivered between RA and CS
or PA are successful in conversion of AI' Positioning of the anodal electrode
in the PA shows slightly higher thresholds and lead impedances than the CS
position. From a practical point of view, however, the pulmonary electrode
is advantageous for positioning a single balloon guided catheter with elec-
trodes in PA and RA position; this is currently under development.
Jurgen Tebbenjohanns, Burghard Schumacher, Dietrich Pfeiffer, Werner Jung,
Berndt Luderitz. Dept. of Cardiology. University of Bonn. Bonn, Germany
Whether slow pathway (SP) ablation is a valuable approach for rate control of
atrial fibrillation (AF) remains unknown. The study inCluded 38 patients with
AV node reentrant tachycardia (AVNRT) in whom AF was induced at base-
line, 30 min and one week after SP ablation. We determined minimum and
maximum cycle length (minCL and maxCL) and the duration of the induced
episode of AI'
Results: AVNRT was successfully abolished in all 38 patients after SP ab-
lation. Abolition of the SP was associated with an increase of minCL during
'pre vs post: p < 0.05, #PROC vs ECV: p < 0.05
Claus Schmitt, Eckhard Alt. Marty Combs, Richard Ammer, Martin Karch,
Edgar Mestre, Martin Coenen. I. Medizinische KJimk. Klinikum rechts der Isar, TV
Miinchen, Germany
There was a significant decrease in the LA-EV and LA-FV after both PROC
and ECV LA-EV in the ECV group pre- and post-cardioversion was signifi-
cantly lower compared to PROe. The left ventricular ejection fraction pre-
cardioversion was lower in the ECV group (44 ± 8% vs 62 ± 9%, p < 0.03).
There were no differences in pre-cardioversion left atrial size, duration of AF
or post-cardioversion mitral A velocities between groups. Three PROC and 4
ECV pts had SC at baseline. SC worsened after conversion to sinus rhythm in
, PROC and 1 ECV pt who required 200J. In conclusion: 1) Cardioversion of
AF, whether chemical or electrical, is associated with a significant decrease
in left atrial appendage function. 2) SC did not worsen after ineffective elec-
trical shocks and did worsen in one PROC ~ I, suggesting that ECV, itself, is
not the cause. 3) The combination of lower filling and emptying velocities of
the left atrial appendage and the lower left ventricular ejection fractions in
the ECV group may be due to more severe heart disease and may identify a
subset of pts resistant to chemical cardioversion. 4) This suggests that left
atrial "stunning" is a result of conversion to sinus rhythm and not a direct
effect of ECV
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Postop AF (n ~ 8)
Effect of Chemical vs Electrical Cardioversion of
Atrial Fibrillation on Left Atrial Appendage
Function and Spontaneous Contrast Formation
Assessed by Transesophageal Echocardiography
PreCPS PostCPS PODl POD2 POD3 POD4
ERP 600 225 ± 39 235 ± 47' 206 ± 34' 223 ± 36 215 ± 24 195 ± 42
ERP 400 195 ± 32 210 ± 40' 195 ± 33 202 ± 32 197 ± 28 206 ± 26
FRP 600 285 ± 42 297 ± 46' 258 ± 37' 268 ± 29' 263 ± 19' 253 ± 20'
FRP 400 262 ± 37 272 ± 37' 250 ± 3D' 249 ± 33 253 ± 21 250 ± 23'
CV400 90 ± 31 82 ± 27' 95 ± 37 102 ± 33 100 ± 49 79 ± 17
WL 18± 6 18± 6 19 ± 8 21 ± 9' 21 ± 13 16± 4
Latency Velocity
Latency Index-l
Latency Index-2
ERP
Latency Wavelength
Rita A. Falcone, Fred Morady, William F. Armstrong. University of Michigan, Ann
Arbor, MI
Cardioversion of atrial fibrillation (AF) transiently increases the risk of stroke,
presumably due to decreased atrial mechanical function and stasis of blood.
It has been suggested that electrical cardioversion (ECV) itself may cause
this phenomenon. We evaluated the effect of chemical vs ECV on left atrial
appendage function and spontaneous contrast (SC) formation during car-
dioversion. Eight pts with AF (>3 days) underwent transesophageal echocar-
diography at baseline, during procainamide infusion (PROC) and during ECV
in increments of 50, 100,200 and 360J if PROC was unsuccessful. All were
anticoagulated and none had left atrial thrombus. Three pts (38%) converted
Conclusion: The ability to generate significant conduction latency dur-
ing premature atrial stimulation appears to be a predictive factor for spon-
taneous occurrence of atrial fibrillation following coronary bypass surgery.
Atrial conduction latency and shortened latency wavelength may be impor-
tant substrates for the initiation of atrial fibrillation.
In conclusion, atrial refractoriness transiently Increases immediately after
cardiac surgery with subsequent shortening by POD 1. This may help to ex-
plain the delayed peak incidence of and vulnerability to postoperative atrial
fibrillation.
Atrial Conduction Latency Predicts Occurrence of
Post Operative Atrial Fibrillation in Patients
Undergoing Coronary Bypass Surgery
Mina K. Chung, Duane P. Pool, Harvey L. Leo, Patrick M. McCarthy, Patrick J. Tchou.
The Cleveland Clinic Foundation, Cleveland, OH
The extent of ventricular conduction latency generated during premature
beats has been related to induction of ventricular fibrillation. We assessed
the relationship of atrial conduction latency during programmed atrial stim-
ulation to the occurrence of post coronary bypass atrial fibrillation (AFI. Pro-
grammed stimulation and recordings were performed on 26 patients under-
going coronary bypass surgery using epicardial wires inserted at the begin-
ning of surgery. Conduction times of premature beats were measured from
stimulus artifact to a distant bipolar electrode pair (5.0 ± 0.3 em). Baseline
conduction time (BCT) was measured during paced beats at 600 ms. Con-
duction latency IL) was defined as the maximal conduction time of premature
beats introduced after 8 paced beats at a cycle length of 600 ms. Latency
index-' (L1-1) was calculated as LlBCl Latency index-2 (L1-2) was generated
as (L-BCT)/BCl Latency velocity (LV) was defined as (electrode distance in
em x 1OOOI/L (msec). Latency wavelength (L-WL) was calculated as effective
refractory period (ERP) x Latency velocity (LV).
Results: 8/26 patients developed atrial fibrillation requiring treatment dur-
ing the post operative period (7 days). The latency velocity was significantly
slower and the latency indices significantly longer in these patients than in
those patients who did not develop atrial fibrillation. The calculated latency
wavelength was shorter in patients who developed postoperative AI'
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Effect of Single Loading Oral Propafenone or
Digoxin in Recent Onset Atrial Fibrillation:
Conversion to Sinus Rhythm and Modulation of
Ventricular Rate. A Randomized, Placebo
Controlled StUdy
after 2 hours
after 4 hours
after 24 hours
Reduction MVR PFN In = 11} DIG (n = 23) PLA (n = 23) P value
baseline (bpm) 134 ± 20 133 ± 29 136 ± 28 I;; < 0.001
after 2 hours 106±22t 113±32t 124 ± 29 vs baseline
(-21%)*' 1-15%) ( -9%)** , = 0.002
after 4 hours 92 ± 151 104 ± 29; 121 ± 27 00 <0.01
1-31 % t l* 1-22% tr (-11%},r 0; ** < 0.05
Conversion to SR
Cardiac Pacing
No serious adverse effects were noted in either group. Phases of regular
tachycardia were observed in 3 pts of each group, but only in 2 cases, both
receiving placebo, 1: 1 AV conduction ensued.
1) Oral loading dose of PFN is safely and promptly efficacious in convert-
ing recent onset AF to SR. 2) The efficacy of oral PFN is significantly superior
in comparison to oral DIG while oral loading dose of DIG is no better than
placebo. 31 PFN and DIG are both effective in reducing MVR in pts with recent
onset AF who did not revert to SR or who reverted late after drug adminis-
tration.
Mean conversion time within 4 hours was 139 ± 117' for PFN, 123 ± 66' for
DIG and 116 ± 78' for PLA (p = ns).
Monday, March 20, 1995, Noon-2:00 p.m.
Ernest N. Morial Convention Center, Hall E
Presentation Hour: 1:00 p.m.-2 :00 p,m.
To date, it is unclear whether handy phones (C-net or D-net) can be used
safely by patients with permanent pacemakers. Possible interactions be-
tween handy phones and pacemaker function include: 1) inhibition of the
pacemaker, 21 change of temporary or permanent pacemaker programming,
and 3) switch to VOO mode.
Methods: Thirty pts (14 f, age: 48-87 years) with single chamber (13 pts)
or dual chamber pacemakers (17 pts) were studied during routine follow-
up in our outpatient department. Pacemaker sensing was unipolar in 17 pts,
and bipolar in 13 pts. After completion of the routine pacemaker check, each
pt was asked to make several phone calls with a handy phone IEricssonR;
D-net; 2.5 watts). A surface ECG (Mingograph) was recorded continuously
during each phone call in order to detect possible interactions between pace-
maker function and handy phone use. Phone calls were repeated after pace-
maker programming to 1) minimum ventricular rate of 90 bpm and previous
sensitivity, and 2) minimum rate of 90 bpm and maximum sensitivity without
T-wave oversensi ng.
Results: A change of the pacemaker programming or a switch to VOO pac-
ing due to handy phone calls was not observed in any pt. Two of 30 pts (3%)
reproducibly showed intermittent pacemaker inhibition during handy phone
calls. Both pacemakers had unipolar sensing. Both pts remained asymp-
tomatic during pacemaker inhibition since they were not completely pace-
A population of 105 patients (pts) with recent onset «72 hours) atrial fibril-
lation (AF) without clinical signs of heart failure were randomly treated with
a single loading oral dose of propafenone (PFN) (600 mg) or digoxin (DIG) (1
mg) or with placebo (PLA). A 24-hour holter monitoring was performed and
conversion to sinus rhythm (SR) after 2, 4 and 24 hours was considered as
criterion of efficacy. We also evaluated the effect on mean ventricular rate
IMVR) in those pts with still lasting AF four hours after drug administration.
The 3 groups were comparable as to gender, age, etiology, duration of AF,
mean ventricular rate at baseline and left atrial dimension.
Interactions Between Handy Phones and
Pacemaker Function in Patients with Permanent
Pacemakers
Wolfram Grimm, Andreas Wilke, Jurgen Hoffmann, Reinhard Funck,
Bernhard Maisch. Philipps-University Marburg, Germany
Giovanni Luca Botto, Walter Bonini, Tiziana Sroffoni, Guido Bernasconi 1,
Mario Frigerio 1, Rossana Lombardi, Santo Molteni, Santo Zerboni,
Giovanni Ferrari. Dept of Cardiology, St. Anna Hosp. Como, Italy: 1Dept of Urgency,
St. Anna Hosp. Como, Italy
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*p < 0.05, #p < 0.01
Conclusion: In pts with AF, precordial OTD increases significantly during
0- but not during S-therapy desp te a comparable increase in OTmax. Tliiis
finding may reflect a greater propensity for the development of proarrhyth-
mia associated with 0 therapy. Determination of OTD may help to increase
the safety of pharmacological therapy in this patient population.
OT dispersion (OTD;OTmax - OTmin) is considered to reflect inhomoge-
neous ventricular recovery. In pts with atrial fibrillation (AF), however, the ef-
fects of antiarrhythmic drugs on OTD have not been systematically evaluated
particularly with respect to their association with drug-induced proarrhyth-
mia. Thus, OTD was assessed in a prospective, randomized trial including 50
pts with AF receiving quinidine (0; 1000 mg/day) or sotalol (S;320 mg/day) in
an attempt to restore sinus rhythm (SRI. Precordial OTD was measured by
means of a digitizer-based software before and during drug therapy. Results:
22/25 O-treated pts converted to SR compared to 17/25 S pts (p = ns). There
were 4 cases of proarrhythmia (torsade de pointes in 3 pts, monomorphic
VT in 1 pt) in the 0- but none in the S-pts. Whereas ventricular depolariza-
tion (ORS) was not affected by either drug, 0 and S caused a comparable
increase in OTmax. OTD, however, increased only in the 0 group whereas no
significant changes were observed in S pts. OTD increased by >50% in all 3
pts with O-associated torsade de pointes.
AF from 353 ± 74 ms to 422 ± 81 ms (p < 0.01) after 30 min, and to 480 ±
99 ms (p < 0.01) after one week. MaxCL (504 ± 125 msl increased to 667 ±
173 ms (p < 0.01). and to 814 ± 467 ms (p < 0.01) respectively. SP ablation
reduced the duration of an AF episode (55 ± 93s) to 14 ± 13s (ns) and to 15
± 16s (ns). No significant difference was observed between the immediate
and follow-up results after one week although a tendency towards higher CL
was demonstrated.
Conclusion: Reduced ventricular response to atrial fibrillation after slow
pathway ablation of AVNRT is demonstrable immediately and during a follow-
up period of one week. Slow pathway ablation may have important implica-
tions for patients with atrial fibrillation refractory to medical treatment.
Quinidine or Sotalol-induced Changes in
QT-Dispersion During Pharmacological
Conversion Therapy of Atrial Fibrillation: Link to
Proarrhythmia as Assessed in a Prospective,
Randomized Trial
The clinical efficacy and safety of oral Sotalol in patients (pts) with refractory
atrial fibrillationlflutter (AF) has not been widely examined. We evaluated 31
pts with chronic (8 pts) or paroxysmal (23 pts) AF, 20 males, mean age 61 ± 8
yrs, LV ejection fraction was ::40 in 11 pts, coronary artery disease in 11 pts,
cardiomyopathy in 5 pts, valvular heart disease in 3 pts, no structural heart
disease in 12 pts. All pts had failed multiple 2.7 (range 1-4) antiarrhythmic
drug trials. Oral Sotalol therapy was commenced during AF in 15 pts and in
sinus rhythm in 16 pts and was titrated to maximally tolerated or effective
levels. All pts underwent 24 hr Holter monitor prior to discharge. Results:
Sotalol resulted in conversion to sinus rhythm in 12 of 15 (80%) pts. 2 pts
had recurrent AF. and 1 pt developed side effects while in the hospital. 28 pts
were discharged on a mean dose of 220 mg daily (range 80-320). During fol-
lowup of 8.2 mas (range 2-20) there were no sudden or cardiac deaths. None
of the pts demonstrated proarrhythmia on Holter monitor. 4 pts (12%) had
recurrence of AF. Sotalol was discontinued in 3 pts (S%) due to side effects.
22 of 31 pts (71 %1 were free of recurrent AF and side effects during fol-
lowup. Conclusions: (1) Sotalol is effective, safe and well tolerated for acute
conversion of AF to sinus rhythm as well as maintenance of sinus rhythm.
(2) Incidence of adverse effects including proarrhythmia is low in this pt pop-
ulation. (3) Effective dose of Sotalol for control of AF seems to be lower than
for ventricular tachycardia.
ORS (msec) aTmax Imsec) OTD (msec)
control drug control drug control drug
a 86 ± 17 gO ± 17 363 ± 38 411 ± 39# 34 ± 9 43 ± 14'
S 89 ± 21 89 ± 18 367 ± 40 425 ± 58# 36 ± 18 40 ± 17
Stefan H. Hohnloser, Frank Baedeker, Andreas van de Loa. University Hospital
Freiburg, Germany
Safety and Efficacy of Sotalol in Drug Refractory
Atrial Fibrillation/Flutter
Ryszard B. Krol, SankarVaranasi, Philip Mathew, Sanjeev Saksena. Eastern Heart
InsMute, Passaic, NJ
